Latest News and Press Releases

Dublin, March 21, 2025 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals in PET Imaging Market - A Global and Regional Analysis: Focus on Radioisotope Type, Application, End User, and Country-Level...

Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds

Dublin, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: The State of the Biopharmaceutical Industry 2025" report has been added to ResearchAndMarkets.com's offering.The research...

Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Equipment Market Size, Share and Trends Analysis Report by Type (SPECT, PET, Planar Scintigraphy Systems), Application (Oncology,...

Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Diagnostic Radiopharmaceuticals and Contrast Media - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...

Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "North America Nuclear Medicine Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...

Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market...

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Canada Nuclear Medicine Market Size, Share & Trends Analysis Report by Product (Diagnostic, Therapeutic), Application (Oncology, Bone Metastasis,...

BEDFORD, Mass. and INDIANAPOLIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus) (NASDAQ: LNTH) and POINT Biopharma Global Inc. (POINT) (NASDAQ: PNT) today announced...

TeleDaaS revolutionizes radiopharmaceutical research by delivering highly-scalable, clinical-grade dosimetry to accelerate cancer treatment breakthroughs.